24 Nov 2020
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/pharmaventures-advises-gpcr-therapeutics-on-their-acquisition-of-burixafor-301179049.html#:~:text=PharmaVentures%20advises%20GPCR%20Therapeutics%20on%20their%20acquisition%20of%20Burixafor,-News%20provided%20by&text=(GPCR)%20providing%20due%20diligence%20for,of%20Burixafor%20for%20worldwide%20markets.
LOOKING FOR A SUPPLIER?